# Azilsartan in Patients With Diabetic Kidney Disease and Hypertension

> **NCT05753696** · NA · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 106 (estimated)

## Conditions studied

- Proteinuria
- Kidney Dysfunction
- Blood Pressure
- Diabetic Kidney Disease

## Interventions

- **DRUG:** Azilsartan
- **DRUG:** Losartan

## Key facts

- **NCT ID:** NCT05753696
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-01
- **Primary completion:** 2024-10-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 106 (ESTIMATED)
- **Last updated:** 2023-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05753696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05753696, "Azilsartan in Patients With Diabetic Kidney Disease and Hypertension". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05753696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*